Epithelial Ovarian Cancer Market

Table of Content

1. Introduction
   • Definition of Epithelial Ovarian Cancer Market
   • Scope of the Report
2. Methodology
   • Executive Summary
   • Market Overview
   • Market Definition and Segmentation
3. Market Dynamics
   • Drivers
   • Restraints
   • Opportunities
   • Porter's Five Forces Analysis
   • PESTEL Analysis
4. Epithelial Ovarian Cancer Market, By Cancer Type:
   • Serous Carcinoma
   • Endometrioid Carcinoma
   • Clear Cell Carcinoma
   • Mucinous Carcinoma
   • Others
5. Epithelial Ovarian Cancer Market, By Stage:
6. Stage I
7. Stage II
8. Stage III
9. Stage IV
10. Epithelial Ovarian Cancer Market, By Treatment Type:
    • Surgery
    • Chemotherapy
    • Radiation Therapy
    • Targeted Therapy
    • Immunotherapy
11. Epithelial Ovarian Cancer Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
12. Epithelial Ovarian Cancer Market, By Biomarker:
    • BRCA1/2 Mutations
    • HER2 Overexpression
    • CA-125
    • PD-L1 Expression
    • Others
13. Epithelial Ovarian Cancer Market, By Age Group:
    • Below 40 years
    • 40-59 years
    • 60 years and above
14. Epithelial Ovarian Cancer Market, By Diagnostic Test:
    • Imaging Tests (Ultrasound, CT Scan, MRI)
    • Blood Tests (CA-125, HE4)
    • Biopsy
15. Epithelial Ovarian Cancer Market, By Risk Factors:
    • Family History of Ovarian or Breast Cancer
    • BRCA Gene Mutations
    • Hormone Replacement Therapy (HRT)
    • Obesity
    • Age
16. Epithelial Ovarian Cancer Market, By End User:
    • Hospitals
    • Specialty Clinics
    • Cancer Treatment Centers
    • Ambulatory Surgical Centers
17. Epithelial Ovarian Cancer Market, By Geography
    • North America
      • United States
      • Canada
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
      • Middle East & Africa
    • Saudi Arabia
      • United Arab Emirates
      • South Africa
      • Rest of Middle East & Africa
18. Competitive Landscape
19. Company Profiles
    • AstraZeneca PLC
      • Company Overview
      • Product Portfolio and Description
      • Key Highlights
      • Financial Overview
    • Roche Holdings AG
    • GlaxoSmithKline PLC
    • Pfizer Inc.
    • Bristol-Myers Squibb Company
    • Merck & Co., Inc.
    • Johnson & Johnson
    • AbbVie Inc.
    • Novartis International AG
    • TESARO, Inc.
    • Clovis Oncology, Inc.
    • Genentech, Inc. (a subsidiary of Roche)
    • Myriad Genetics, Inc.
    • Foundation Medicine, Inc.
    • Guardant Health, Inc.
20. Conclusion and Future Outlook
21. Appendix
    • Research Methodology
    • About the Pharmanucleus
22. Disclaimer